These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6358036)

  • 21. Lethal effect of complement and lysozyme on polymyxin-treated, serum-resistant gram-negative bacilli.
    Fierer J; Finley F
    J Infect Dis; 1979 Oct; 140(4):581-9. PubMed ID: 229175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.
    Madsen LM; Inada M; Weiss J
    Infect Immun; 1996 Jul; 64(7):2425-30. PubMed ID: 8698462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement-mediated inhibition of function in complement-resistant Escherichia coli.
    Dankert JR
    J Immunol; 1989 Mar; 142(5):1591-5. PubMed ID: 2645364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9.
    Puentes SM; Da Silva RP; Sacks DL; Hammer CH; Joiner KA
    J Immunol; 1990 Dec; 145(12):4311-6. PubMed ID: 2147941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interrelationship between serum beta-lysin, lysozyme, and the antibody-complement system in killing Escherichia coli.
    Donaldson DM; Roberts RR; Larsen HS; Tew JG
    Infect Immun; 1974 Sep; 10(3):657-66. PubMed ID: 4609906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum resistance in an invasive, nontypeable Haemophilus influenzae strain.
    Williams BJ; Morlin G; Valentine N; Smith AL
    Infect Immun; 2001 Feb; 69(2):695-705. PubMed ID: 11159957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.
    Joiner KA; Schmetz MA; Sanders ME; Murray TG; Hammer CH; Dourmashkin R; Frank MM
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4808-12. PubMed ID: 3895225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9.
    O'Hara AM; Moran AP; Würzner R; Orren A
    Immunology; 2001 Mar; 102(3):365-72. PubMed ID: 11298837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.
    Vaara M; Viljanen P; Vaara T; Mäkelä PH
    J Immunol; 1984 May; 132(5):2582-9. PubMed ID: 6325539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4.
    Joiner KA; Goldman R; Schmetz M; Berger M; Hammer CH; Frank MM; Leive L
    J Immunol; 1984 Jan; 132(1):369-75. PubMed ID: 6197449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of complement activation at the C3-level by serum resistant leptospires.
    Meri T; Murgia R; Stefanel P; Meri S; Cinco M
    Microb Pathog; 2005 Oct; 39(4):139-47. PubMed ID: 16169184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Killing of gram-negative bacteria by complement. Fractionation of cell membranes after complement C5b-9 deposition on to the surface of Salmonella minnesota Re595.
    Tomlinson S; Taylor PW; Morgan BP; Luzio JP
    Biochem J; 1989 Oct; 263(2):505-11. PubMed ID: 2597121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mechanism of acquired resistance to complement-mediated lysis by Entamoeba histolytica.
    Gutiérrez-Kobeh L; Cabrera N; Pérez-Montfort R
    J Parasitol; 1997 Apr; 83(2):234-41. PubMed ID: 9105303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen.
    Goldman RC; Joiner K; Leive L
    J Bacteriol; 1984 Sep; 159(3):877-82. PubMed ID: 6207166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
    Stewart JL; Monahan JB; Brickner A; Sodetz JM
    Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cytolytic C5b-9 complement complex: feedback inhibition of complement activation.
    Bhakdi S; Maillet F; Muhly M; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1912-6. PubMed ID: 3162317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
    Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of nourseothricin (streptothricin) on the outer membrane of sensitive and resistant Escherichia coli strains.
    Seltmann G; Wolter EJ
    J Basic Microbiol; 1987; 27(3):139-46. PubMed ID: 3040961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.